Literature DB >> 24816419

Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice?

Yusuf A Rajabally1, Marie-Christine Durand2, James Mitchell1, David Orlikowski3, Guillaume Nicolas4.   

Abstract

BACKGROUND: Serial electrophysiology has been suggested as essential for accurate diagnosis in Guillain-Barré syndrome (GBS). However, whether more adapted electrophysiological criteria may allow a single study to be sufficient is unknown.
METHODS: We retrospectively reviewed records of 365 consecutive patients with GBS from Birmingham, U.K., and Garches, France, admitted between 1998 and 2013. Electrophysiology was analysed using existing criteria as well as a set of modified criteria, developed using sensitive and specific cut-off values for demyelination and incorporating new knowledge on electrophysiology of axonal GBS. We compared diagnostic rates and classification changes using modified criteria with published literature relating to serial studies.
RESULTS: With existing criteria, we found similar proportions of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) (71.5% vs. 72%; p=1), axonal GBS (17.5% vs. 14.7%; p=0.62) and equivocal forms (9.9% vs. 13.3%; p=0.41) to the previous studies considered. With modified criteria, we identified comparable rates of AIDP (56.2% vs. 58.7%; p=0.70), axonal GBS (35.1% vs. 36%; p=0.89) and equivocal forms (7.7% vs. 5.3%; p=0.63) with a single nerve conduction study as compared with when serial electrophysiology was used in previous analyses. We observed an identical diagnostic shift from AIDP to axonal GBS with modified criteria as that described with serial studies (21.5% vs. 18.5%; p=0.72). Classification changes with modified criteria correlated significantly with performing of electrophysiology ≤7 days after symptom onset (p=0.045), indicating their greater usefulness in earlier disease stages.
CONCLUSIONS: A single electrophysiological study may suffice to establish the ultimate electrodiagnosis of GBS subtype if the proposed modified electrodiagnostic criteria are used. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  GUILLAIN-BARRE SYNDROME; NEUROMUSCULAR; NEUROPATHY; NEUROPHYSIOL, CLINICAL

Mesh:

Year:  2014        PMID: 24816419     DOI: 10.1136/jnnp-2014-307815

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

Review 1.  Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.

Authors:  Eva L Feldman; Richard A C Hughes; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2015-10-13       Impact factor: 42.937

2.  How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India.

Authors:  Pradeep Kumar Gupta; Pratibha Singhi; Sunit Singhi; Ananthanarayanan Kasinathan; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2019-01-12       Impact factor: 1.967

3.  Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.

Authors:  Pierre R Bourque; J Brooks; J Warman-Chardon; A Breiner
Journal:  J Neurol       Date:  2019-11-16       Impact factor: 4.849

4.  Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barré syndrome-a case report.

Authors:  S Coniglio; G Turchi; G Giovannini; M Mazzoli; S Meletti; Anna Elisabetta Vaudano
Journal:  Neurol Sci       Date:  2022-04-07       Impact factor: 3.307

5.  Neurophysiological Aspects in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.

Authors:  Eleonora Vecchio; Lara Gallicchio; Nicola Caporusso; Valentina Recchia; Luigi Didonna; Giancarlo Pezzuto; Luigi Pisani; Antonella Petruzzellis; Vito Delmonte; Filippo Tamma
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

6.  Old age and multiple comorbidity are associated with delayed diagnosis of Guillain-Barre syndrome.

Authors:  Sohyeon Kim; Hee Jo Han; Ha Young Shin; Seung Woo Kim
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

7.  Guillain-Barré or Guillain-Barré-Strohl syndrome: medical and non-medical reasons for omitting Andre Strohl from the eponym.

Authors:  Łukasz Rzepiński; Andrzej Grzybowski
Journal:  Arch Med Sci       Date:  2022-06-23       Impact factor: 3.707

Review 8.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

9.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

10.  Modified Zipper Method, a Promising Treatment Option in Severe Pediatric Immune-Mediated Neurologic Disorders.

Authors:  Marc Nikolaus; Fabienne Kühne; Anna Tietze; Julia Thumfart; Caroline Kempf; Alexander Gratopp; Ellen Knierim; Petra Bittigau; Angela M Kaindl
Journal:  J Child Neurol       Date:  2022-04-18       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.